| __timestamp | Corcept Therapeutics Incorporated | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 25669000 | 1256834000000 |
| Thursday, January 1, 2015 | 48925000 | 1271973000000 |
| Friday, January 1, 2016 | 79263000 | 1173296000000 |
| Sunday, January 1, 2017 | 155647000 | 1274610000000 |
| Monday, January 1, 2018 | 246032000 | 1437534000000 |
| Tuesday, January 1, 2019 | 300982000 | 2201424000000 |
| Wednesday, January 1, 2020 | 348292000 | 2203504000000 |
| Friday, January 1, 2021 | 360697000 | 2462160000000 |
| Saturday, January 1, 2022 | 396473000 | 2783406000000 |
| Sunday, January 1, 2023 | 475894000 | 2832257000000 |
| Monday, January 1, 2024 | 2832257000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. This analysis delves into the gross profit trends of Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated over the past decade. Takeda, a global leader, consistently showcases robust financial health, with gross profits soaring from approximately 1.26 trillion in 2014 to 2.83 trillion in 2023, marking a 125% increase. Meanwhile, Corcept, a niche player, has demonstrated impressive growth, with gross profits rising from 25.7 million in 2014 to 475.9 million in 2023, a staggering 1,750% increase. Despite the vast difference in scale, both companies highlight the dynamic nature of the pharmaceutical sector. Notably, data for Corcept in 2024 is unavailable, indicating potential reporting delays or strategic shifts. This comparison underscores the diverse strategies and market positions within the industry.
Sanofi vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Comparison: GSK plc and Corcept Therapeutics Incorporated Trends
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends